Japanese Auto Components Stock News

TSE:9697
TSE:9697Entertainment

Capcom (TSE:9697) Valuation Check As Resident Evil Requiem Surpasses 6 Million Units

Capcom (TSE:9697) is back in focus after Resident Evil Requiem sales surpassed 6 million units, reaching this milestone faster than any prior series entry and coinciding with extensive 30th anniversary content and collaboration plans. See our latest analysis for Capcom. Those game successes and esports events have come alongside a 17.0% 1 month share price return and a softer year to date share price performance of 2.4% decline. Meanwhile, 3 year total shareholder return sits at 62.1%,...
TSE:2871
TSE:2871Food

How Nichirei’s European Cold-Chain Expansion Capital Injection Will Impact Nichirei (TSE:2871) Investors

Nichirei Corporation recently held a board meeting where it approved a substantial capital increase for its European sub-subsidiary, Nichirei Holding Holland B.V., to fund new refrigerated warehouses and expand cold-chain logistics operations across Europe. This move underlines Nichirei’s intent to deepen its presence in the European cold-chain market by enhancing high value-added logistics services and long-term operating capabilities. We will now examine how this capital injection into...
TSE:4503
TSE:4503Pharmaceuticals

How Investors Are Reacting To Astellas Pharma (TSE:4503) XOSPATA Frontline AML Trial Missing Survival Goal

Astellas Pharma and the HOVON Foundation reported that the Phase 3 HOVON 156/AMLSG 28-18/PASHA trial of XOSPATA (gilteritinib) in newly diagnosed FLT3-mutated acute myeloid leukemia did not meet its primary endpoint of overall survival at the primary analysis, with overall survival and safety broadly similar to midostaurin-based treatment. Although Astellas expects only a minor impact on financial results for the fiscal year ending March 31, 2026, the outcome underscores how clinical...
TSE:8750
TSE:8750Insurance

What Dai-ichi Life Holdings (TSE:8750)'s Completed Share Buyback Means For Shareholders

Dai-ichi Life Holdings has completed its share repurchase program announced in May 2025, buying back 79,682,200 shares, or 2.18% of its stock, for ¥99,999.99 million, with the final tranche executed between January 1 and March 9, 2026, and the plan formally closed on March 9. This completed buyback meaningfully reduces the share count and underscores management’s capital return focus at a time of ongoing business transformation. We’ll now examine how the completion of this sizeable share...
TSE:8088
TSE:8088Oil and Gas

Why Iwatani (TSE:8088) Is Up 12.7% After Qatar Helium Disruptions Test Its Supply Resilience

Disruptions to Qatar’s natural gas processing during the Iran war have pushed helium prices sharply higher, exposing global supply vulnerabilities while Iwatani, Japan’s leading helium supplier, reports it has so far kept deliveries stable through US sourcing and stockpiles. The episode highlights how concentrated helium production leaves industrial gas companies like Iwatani highly exposed to geopolitical risk despite contingency measures. Next, we’ll examine how heightened geopolitical...
TSE:3462
TSE:3462REITs

A Look At Nomura Real Estate Master Fund’s Valuation After Its Latest Tokyo-Focused Portfolio Repositioning

Nomura Real Estate Master Fund (TSE:3462) is reshaping its portfolio by selling the aging NRE Hiroshima Building and acquiring two newer Tokyo properties, GEMS Tachikawa and PROUD FLAT Kiyosumidori, for a combined ¥8,880 million. See our latest analysis for Nomura Real Estate Master Fund. Recent asset recycling comes as the unit price has shown mixed momentum, with a 1 year total shareholder return of 20.33% contrasting with a weaker year to date share price return of a 5.32% decline. This...
TSE:9008
TSE:9008Transportation

Keio (TSE:9008) Valuation Check After Completed Share Buyback And New ¥10b Green Bond Issuance

Keio (TSE:9008) has just wrapped up a share repurchase program and completed a ¥9,999.75 million buyback, while also issuing ¥10 billion in unsecured green bonds with a fixed 1.537% coupon. See our latest analysis for Keio. Keio's latest ¥3,887 share price comes after a 1 day share price return of 0.67%. However, the 30 day share price return of a 4.64% decline and the 5 year total shareholder return of a 45.55% loss suggest longer term momentum has been weak, even as the recent buyback and...
TSE:4368
TSE:4368Chemicals

Assessing Fuso Chemical (TSE:4368) Valuation After Kyoto Plant Manufacturing Expansion Review

Fuso ChemicalLtd (TSE:4368) has drawn fresh attention after a 13 March 2026 board meeting to review a manufacturing facility plan for its Kyoto Plant, raising questions about future capacity and capital allocation. See our latest analysis for Fuso ChemicalLtd. At a share price of ¥9,240.0, Fuso ChemicalLtd has seen firm momentum recently, with a 1 day share price return of 3.94% and a 90 day share price return of 46.90%. The 1 year total shareholder return of 161.92% points to strong longer...
TSE:9201
TSE:9201Airlines

Assessing Japan Airlines (TSE:9201) Valuation After Upgraded Earnings Guidance And Dividend Forecast

Japan Airlines (TSE:9201) updated investors on 2 March 2026 by raising its earnings guidance, lifting dividend forecasts for the current fiscal year, and initiating work on a new growth strategy following a board meeting. See our latest analysis for Japan Airlines. Despite the raised earnings and dividend guidance, Japan Airlines’ 30 day share price return of 16.7% and year to date share price return decline of 12.2% suggest momentum has recently cooled, even though the 1 year total...
TSE:2501
TSE:2501Beverage

Assessing Sapporo Holdings (TSE:2501) Valuation After Recent Share Price Weakness

Event context and recent share moves Sapporo Holdings (TSE:2501) shares recently closed at ¥1,625, with a 0.8% move over the past day, a 2.7% decline over the past week, and a 13.6% decline over the past month. See our latest analysis for Sapporo Holdings. The recent 13.6% 1 month share price return contrasts with a slightly positive 90 day move and is set against a 1 year total shareholder return of 4.7%. This suggests momentum has cooled after a strong multi year run that includes a very...
TSE:4151
TSE:4151Pharmaceuticals

Does Ending Rocatinlimab Trials Over Safety Concerns Change The Bull Case For Kyowa Kirin (TSE:4151)?

In early March 2026, Kyowa Kirin Co., Ltd. announced it would discontinue all clinical trials of rocatinlimab, an investigational anti-OX40 antibody for moderate-to-severe atopic dermatitis, prurigo nodularis, and asthma, following a planned safety review conducted with partner Amgen. The decision was driven by emerging malignancy signals, including confirmed and suspected cases of Kaposi’s sarcoma that, despite low overall incidence, raised plausible mechanistic concerns about OX40 pathway...
TSE:8308
TSE:8308Banks

How Investors Are Reacting To Resona Holdings (TSE:8308) Elevating Insiders To Steer Finance, Digital And Talent

Resona Holdings, Inc. recently approved changes to its top leadership, appointing long-time insider Shinichiro Isa as Deputy President, Representative Executive Officer, Group CFO and Group CDO, and elevating Nobuki Iwadate to Group Chief Human Resources Officer, Deputy President and Representative Executive Officer, effective April 1, 2026. The concentration of financial, digital and human capital oversight in the hands of two experienced internal leaders may meaningfully influence how...
TSE:8630
TSE:8630Insurance

Sompo Holdings (TSE:8630) Valuation Check As Governance Reforms And Trust Recovery Take Center Stage

Sompo Holdings (TSE:8630) has put governance and trust at the center of its story, updating regulators on reforms around fraudulent auto claims, premium practices, and data leaks that previously challenged its reputation. See our latest analysis for Sompo Holdings. Alongside these governance updates and the Aspen integration in the UK, Sompo Holdings’ ¥5,829 share price comes after a 90 day share price return of 12.10% and a 1 year total shareholder return of 32.92%. The 3 year total...
TSE:8473
TSE:8473Capital Markets

A Look At SBI Holdings (TSE:8473) Valuation After Dividend Hike And ¥50b Share Buyback

Why SBI Holdings (TSE:8473) just moved its dividend goalposts SBI Holdings (TSE:8473) has raised its year end dividend forecast to ¥75 per share and highlighted a completed ¥50b share buyback, following a board decision tied to profits in its Financial Services Business. See our latest analysis for SBI Holdings. The updated dividend and completed ¥50b buyback come after a weaker run in the share price, with a 30 day share price return of 17.6% and a year to date return of 14.26%. This...
TSE:5844
TSE:5844Banks

Kyoto Financial Group (TSE:5844) Valuation After Earnings Upgrade Special Dividend And Expanded Buyback

Kyoto Financial Group Inc (TSE:5844) has drawn investor attention after sharply raising its earnings guidance, funded by large gains on equity sales, and pairing that move with a special dividend and expanded share buyback plan. See our latest analysis for Kyoto Financial GroupInc. The flurry of guidance upgrades, special dividend plans and the expanded buyback has coincided with strong recent momentum, with a 30 day share price return of 15.21% and a 1 year total shareholder return of...
TSE:4967
TSE:4967Personal Products

Assessing Kobayashi Pharmaceutical (TSE:4967) Valuation After Oasis Management’s Governance Challenge

Governance dispute focuses attention on Kobayashi Pharmaceutical Oasis Management’s public campaign against Kobayashi Pharmaceutical (TSE:4967) and its move to a Company with an Audit and Supervisory Committee has pushed the company’s governance structure and board oversight firmly into the spotlight for shareholders. See our latest analysis for Kobayashi Pharmaceutical. The governance dispute has arrived after a period where the 90 day share price return of 7.41% contrasts with a weaker 3...
TSE:7013
TSE:7013Machinery

Assessing IHI (TSE:7013) Valuation After Recent Share Price Pullback And Long Term Rerating

Why IHI (TSE:7013) is on investors’ radar today IHI (TSE:7013) has recently drawn attention after a period of mixed share performance, with a negative month but a strong past 3 months and 1 year total return. This has prompted fresh questions about how its current valuation lines up with fundamentals. See our latest analysis for IHI. At a share price of ¥3,734.0, IHI has recently seen a 10.02% 1 month share price decline, following a strong 27.42% 3 month share price return and a very large 5...
TSE:3774
TSE:3774Telecom

Assessing Internet Initiative Japan (TSE:3774) Valuation After Launch Of New Internal Security Assessment Service

Internet Initiative Japan (TSE:3774) has introduced a new Internal Vulnerability Assessment service within its Safous Security Assessment offering, giving customers broader visibility into security risks across internal networks and distributed sites. See our latest analysis for Internet Initiative Japan. The new security service arrives as Internet Initiative Japan’s share price trades at ¥2,333.5, with a 7 day share price return of 3.55% and a 30 day share price return of 4.97%. This...
TSE:8306
TSE:8306Banks

New MUFG Leaders May Steer Capital Priorities For Undervalued Shares

Mitsubishi UFJ Financial Group (TSE:8306) has announced significant leadership changes at the senior executive level. Takuya Tanaka has been appointed Senior Managing Corporate Executive with responsibilities linked to commercial banking and wealth management. Yoshiaki Ueno has been appointed Managing Corporate Executive with a focus on corporate planning and group level management. These appointments mark a reshuffling of top roles that could influence group wide priorities and capital...
TSE:3480
TSE:3480Real Estate

J.S.B.Co.Ltd (TSE:3480) Swing Back To Q1 Profit Tests Volatility Narrative

J.S.B.Co.Ltd (TSE:3480) opened Q1 2026 with revenue of ¥16.8b and basic EPS of ¥18.13, alongside trailing twelve month EPS of ¥285.67 on revenue of ¥77.6b. Over recent quarters the company has seen quarterly revenue move between ¥15.3b and ¥27.0b while basic EPS has ranged from a loss of ¥24.20 per share to a profit of ¥267.87 per share, giving investors a wide set of earnings outcomes to weigh against the current print. With trailing net profit margin at 7.8% compared with 7.3% a year...
TSE:2929
TSE:2929Biotechs

Pharma Foods International Q2 Profit Challenges Bearish Earnings Narratives

Pharma Foods International (TSE:2929) has just posted its Q2 2026 numbers, with revenue of ¥16.7 billion and basic EPS of ¥2.31, alongside net income of ¥67 million. Over the last six quarters, the company has seen quarterly revenue move between ¥14.6 billion and ¥18.4 billion. Basic EPS has swung from a loss of ¥65.50 to a gain of ¥51.59 before landing at the latest ¥2.31 print, which puts the spotlight firmly on how much of that top line is actually flowing through to shareholders. For...
TSE:3193
TSE:3193Hospitality

Eternal Hospitality GroupLtd (TSE:3193) EPS Slide To ¥25 Challenges Bullish Growth Narratives

Eternal Hospitality GroupLtd (TSE:3193) has posted its Q2 2026 numbers with revenue of ¥12.8 billion and basic EPS of ¥25.03, alongside net income of ¥288.78 million, giving investors a clear snapshot of mid year trading. The company has seen quarterly revenue move from ¥11.2 billion in Q2 2025 to ¥12.8 billion in Q2 2026, while basic EPS shifted from ¥28.28 to ¥25.03 over the same period, and investors will be weighing these trends against the latest margin picture and how efficiently those...
TSE:3159
TSE:3159Specialty Retail

Maruzen CHI Holdings (TSE:3159) Margin Compression To 1.8% Tests Bullish Narratives

Maruzen CHI HoldingsLtd (TSE:3159) has wrapped up FY 2026 with fourth quarter revenue of ¥43.3b and basic EPS of ¥2.47, rounding out a year where quarterly revenue ranged between ¥43.1b and ¥49.3b and EPS moved from ¥17.29 in Q1 to ¥2.47 in Q4. Across the latest trailing twelve months, revenue came in at ¥185.1b with basic EPS of ¥36.03, which may encourage investors to focus less on headline growth stories and more on how the business is converting that top line into earnings. With trailing...
TSE:4996
TSE:4996Chemicals

Kumiai Chemical Industry Q1 Margin Compression Challenges Bullish Earnings Growth Narrative

Kumiai Chemical Industry (TSE:4996) has opened fiscal 2026 with Q1 revenue of ¥46,707 million and basic EPS of ¥32.74, setting a fresh reference point after a volatile run of quarterly earnings. The company has seen revenue move from ¥43,381 million in Q1 2025 to ¥46,707 million in Q1 2026, while basic EPS shifted from ¥33.25 to ¥32.74 over the same periods. This gives investors a clean snapshot of the top and bottom line as they weigh how a thinner 2.5% trailing net margin and that prior...